Just Cause is CRAZY Beautiful 2# – Cinematic Tour of Panau Islands [HD] – Video

Posted on by


Just Cause is CRAZY Beautiful 2# - Cinematic Tour of Panau Islands [HD]
Second and last part of the virtual tour around Panau Island. In this episode the Southern Islands, with its Deserts and Forests Part 1: https://www.youtube.com/watch?v=1ZePB7AZTZg If you...

By: Nadeox1

Read more:

Just Cause is CRAZY Beautiful 2# - Cinematic Tour of Panau Islands [HD] - Video

Marshall Islands Case against the Nuclear-Armed States

Posted on by

Marshall Islands launches case against the Nuclear-Armed States in the International Court of Justice Press Release April 24, 2014

The Republic of the Marshall Islands today filed lawsuits in the International Court of Justice (ICJ) against the nine nuclear-armed states holding them accountable for flagrant violations of international law with respect to their nuclear disarmament obligations. The Marshall Islands, which was used for 12 years as a testing ground for nuclear bombs by the United States, says the five original nuclear weapon states U.S., Russia, UK, France and China are continuously breaching their legal obligations under the 1968 Nuclear Non-Proliferation Treaty (NPT). The lawsuits also contend that all nine nuclear-armed nations are violating customary international law.

The nuclear armed States have an obligation affirmed by the International Court of Justice in a 1996 Advisory Opinion to achieve the complete elimination of nuclear weapons under strict and effective international control, says Alyn Ware, Consultant for the International Association of Lawyers Against Nuclear Arms and the United Nations Coordinator for the World Court Project which launched the 1996 ICJ Advisory Opinion. They have flagrantly violated this obligation by not even commencing the required negotiations.

The Marshall Islands was one of the leading countries arguing against nuclear weapons in the 1996 ICJ Advisory Opinion, along with a number of other countries including Australia, Costa Rica, Egypt, Indonesia, Malaysia, Mexico, New Zealand, Philippines, Qatar, Samoa, San Marino and the Solomon Islands. Based on testimony placed before the ICJ in 1996 by the World Health Organisation, the Mayors of Hiroshima and Nagasaki, the Marshall Islands and others, the ICJ stated that the destructive effects of nuclear weapons could not be contained in time or space, and that the threat or use of nuclear weapons was thus generally illegal under international law applicable in wartime including international humanitarian law.

In a press release announcing the lodging of the lawsuits against the nuclear-armed states today (attached), Marshall Islands Foreign Minister Tony de Brum said Our people have suffered the catastrophic and irreparable damage of these weapons, and we vow to fight so that no one else on earth will ever again experience these atrocities. The continued existence of nuclear weapons and the terrible risk they pose to the world threaten us all.

The press release notes that three of the nine states, the UK, India, and Pakistan, have accepted the compulsory jurisdiction of the World Court when the opposing state equally has done so, as has the Marshall Islands. As to the other six states, the Marshall Islands is calling on them to accept the jurisdiction of the Court for this particular case and explain to the Court their positions regarding the nuclear disarmament obligations.

The failure of these nuclear-armed countries to uphold important commitments and respect the law makes the world a more dangerous place, said Archbishop Desmond Tutu, a vocal backer of the lawsuits. We must ask why these leaders continue to break their promises and put their citizens and the world at risk of horrific devastation. This is one of the most fundamental moral and legal questions of our time.

The lawsuits filed today in the International Court of Justice in The Hague are accompanied by a related lawsuit brought in U.S. Federal District Court in San Francisco against the United States.

PRESS RELEASE FROM NETHERLANDS Pacific Nation Challenges Nine Nuclear-Armed States in Lawsuits before the World Court

Republic of Marshall Islands Historic Lawsuits Charge the U.S., Russia, UK, France, China, Israel, India, Pakistan and North Korea with Breaches of International Law

More:

Marshall Islands Case against the Nuclear-Armed States

Central African Republic: The challenges of treating war wounded – Video

Posted on by


Central African Republic: The challenges of treating war wounded
Wounded and sick without access to health care, damaged and looted medical facilities and health-care personnel experiencing or fearing attacks -- this is the staggering reality in Central...

By: International Committee of the Red Cross (ICRC)

Original post:

Central African Republic: The challenges of treating war wounded - Video

Chinese health care system and my opinion on it – personal video – HTMMG – Video

Posted on by


Chinese health care system and my opinion on it - personal video - HTMMG
If you would like to send a donation to the channel, here the link: https://www.paypal.com/cgi-bin/webscr?cmd=_donations business=macfinch%40hotmail%2eco%2euk lc=GB item_name=How%20To%20Make%20Mobi...

By: HowToMakeMobileGames

Read this article:

Chinese health care system and my opinion on it - personal video - HTMMG - Video

How analytics can deliver insight for health care IT services

Posted on by

(MENAFN - Arab News) The health care it industry is increasingly dynamic in the middle east.

according to gartner health care providers in the middle east and africa will spend 2.8 billion on it products and services in 2014 an increase of 2.8 percent over 2013.

analysts predict that saudi arabia gcc's biggest economy will continue its focus on building health care infrastructure to support its growing population and the uae is expected to enhance its focus on building patient databases mobile health and preventive health care.

even though there is growth in the health care industry health care it professionals have long been expected to deliver more in terms of quality while containing costs with ict services working toward this overall objective. with responsibility for the management of the hospital's it infrastructure they are constantly seeking ways of delivering improved levels of system availability performance and service quality.

users of technology in the health care industry expect their it systems to work delivering what they need when they need it. lives can depend on this.

better management of a hospital's it infrastructure should help meet this expectation ensuring hospital end-users (doctors nurses and administrative staff) have access to medical applications and electronic patient data at any time from any location to ensure the best patient care.

an effective way of meeting these objectives is the deployment of robust it analytics which will provide hospitals with clear visibility into the health and performance of their it infrastructure. inefficiencies disruptions and failures can be identified automatically as they occur and often before end-users are even aware of them.

monitor manage and respond

the management of a hospital's it infrastructure is increasingly outsourced with sub-contractors running an it service desk for example. without direct involvement however a hospital's ict manager may experience a sense that they no longer have full control of the workings of their infrastructure; that they lack the visibility needed to know what's happening at any given time.

with real-time intelligence and the level of management reporting provided by it analytics the hospital ict manager can be more aware of what's occurring across the infrastructure.

The rest is here:

How analytics can deliver insight for health care IT services

UH helps create hub for environmental experts

Posted on by

Three Texas universities are joining together to create ahome for environmental investigators, funding infrastructure needs with a $4.4 million grant from the National Institutes of Health,funding the first-ever hub for researchers looking for connections between genetic traits and environmental health factors.

UH, Texas A&M University and Baylor College of Medicine are teaming up to create thecenter, named by the National Institutes of Health as the newest national Center of Excellence in Environmental Health Science. It will be led by research team leader Cheryl Lyn Walker, director of the Texas A&M Health Science Center Institute of Biosciences and Technology andCollege ofVeterinary Medicine & Biomedical Sciences.

In addition to the $4.4 million NIH grant, researchers will be using their own existing grants and seeking additional grants to do their work, said Jeannie Kever, senior media relations specialist at UH.

As reported by the Eagle, this center is a cross-institutional initiative to promote integrated environmental health research and translate research advances into practices that can improve human health.

The grant will pay for the centers infrastructure needs and provide $250,000 in seed grants through a pilot program, officials said in a press release.

This is a game-changer, Walker said in a press release. We knew it needed to be an intercollegiate effort.

The Texas A&M Health Science Center is leading the centers development with collaboration from AgriLife Research, the Bush School of Government and Public Service,the Collegeof Education and Human Development, the College of Medicine, the College of Veterinary Medicine & Biomedical Sciences and the Dwight Look College of Engineering. That network is expanded with help from the Baylor College of Medicine and University of Houston researchers in the Texas Medical Center.

This is a great opportunity for major Texas institutions to address the environmental health issues of Texas, said Melissa Bondy, professor in the National Cancer Institute-designated Dan L. DuncanCancer Centerat the Baylor College of Medicine and associate director of the new center, in a UH press release.

news@thedailycougar.com

Read this article:

UH helps create hub for environmental experts

Minn. lawmakers consider GMO label

Posted on by

ST. PAUL A produced with genetic engineering label could one day make its appearance in Minnesota stores.

Rep. Karen Clark, D-Minneapolis, sponsors a bill to regulate disclosure of genetically engineered food and seed. The House commerce committee held an informational hearing on the bill Thursday. There is no Senate companion and the House committee took no vote.

This is a bill about the basic right of consumers to know whats in their food whether or not their food contains genetically modified compounds, Clark said.

According to the bill, genetically modified foods for sale would be required to have a label conspicuously placed on the packaging or shelf (for unpackaged foods) that says produced with genetic engineering.

Genetically modified seed would have such labeling on the seed container, receipt or other form of product identification.

The bill also consists of enforcement provisions and a section describing some research into the negative effects of genetically engineered food such as herbicide resistance in weeds and an increase in the use of insecticides.

Perry Aasness, executive director of the Minnesota Agri-Growth Council, said that science has shown that genetically engineered foods are essentially identical to conventional varieties and pose no greater risk than non-GMO food products.

He said that he is not opposed to labeling requirements, but believes the federal government, through the Food and Drug Administration, should develop voluntary labeling standards.

Jamie Pfuhl, president of the Minnesota Grocers Association, agreed with allowing the federal government to enact labeling legislation. A state-by-state approach would create a patchwork of regulations, she said, a challenge for stores that receive products from other states and countries.

Foods exempted from the labeling requirements under the bill would include:

Read more:

Minn. lawmakers consider GMO label

Gene therapy may help hearing

Posted on by

Australian researchers are trying a novel way to boost the power of cochlear implants: They used the technology to beam gene therapy into the ears of deaf animals and found it improved hearing.

The approach isn't ready for human testing, but it's part of growing research into ways to let users of cochlear implants experience richer, more normal sound.

Normally, microscopic hair cells in a part of the inner ear called the cochlea detect vibrations and convert them to electrical impulses that the brain recognizes as sound. Hearing loss typically occurs as those hair cells are lost, whether from aging, exposure to loud noises or other factors.

Cochlear implants substitute for the missing hair cells, sending electrical impulses to directly activate auditory nerves in the brain. They've been implanted in more than 300,000 people. While highly successful, they don't restore hearing to normal, missing out on musical tone, for instance.

The idea behind the project: Perhaps a closer connection between the implant and the auditory nerves would improve hearing. Those nerves' bushlike endings can regrow if exposed to nerve-nourishing proteins called neurotrophins. Usually, the hair cells would provide those.

Researchers at Australia's University of New South Wales figured out a new way to deliver one of those growth factors.

They injected a growth factor-producing gene into the ears of deafened guinea pigs, animals commonly used as a model for human hearing. Then they adapted an electrode from a cochlear implant to beam in a few stronger-than-normal electrical pulses.

That made the membranes of nearby cells temporarily permeable, so the gene could slip inside. Those cells began producing the growth factor, which in turn stimulated regrowth of the nerve.

-- from wire reports

Read the original:

Gene therapy may help hearing

Cochlear implant enhances patient experience through gene therapy

Posted on by

According to the World Health Organization, more than 360 million people worldwide live with disabling hearing loss, and for many, devices such as hearing aids and cochlear implants allow them to maintain a normal life style. But what if a cochlear device could offer a biological solution that would enhance a patients experience?

For the first time, researchers at the University of New South Wales in Australia have used cochlear implants to regenerate auditory nerves through gene therapy, a process where therapeutic DNA is inserted into cells to treat a disease.

Cochlear implants work by converting sounds into electrical signals that are sent directly to the auditory nerve, bypassing the outer and middle ear. The process allows for significantly improved hearing, including the ability to maintain a phone conversation, but the sounds they provide for patients are monotone and robotic.

Ultimately, we hope that after further research, people who depend on cochlear implant devices will be able to enjoy a broader dynamic and tonal range of sound, which is particularly important for our sense of the auditory world around us and for music appreciation, says Professor Gary Housley, Director of the Translational Neuroscience Facility at UNSW Medicine.

In 1993 multiple labs discovered that mammals ears would have the ability to regenerate cells if triggered according to the National Organization for Hearing Research Foundation, but until now there hadnt been a safe or efficient way to deliver the necessary proteins to the cochlear area.

We think its possible that in the future this gene delivery would only add a few minutes to the implant procedure, says the papers first author, Jeremy Pinyon, whose PhD is based on this work. The surgeon who installs the device would inject the DNA solution into the cochlea and then fire electrical impulses to trigger the DNA transfer once the implant is inserted.

Gene therapy research has provided hope for a number of genetic disorders and diseases, including cancer, HIV and multiple sclerosis.

"Our work has implications far beyond hearing disorders, says co-author Associate Professor Matthias Klugmann, from the UNSW Translational Neuroscience Facility research team. Gene therapy has been suggested as a treatment concept even for devastating neurological conditions and our technology provides a novel platform for safe and efficient gene transfer into tissues as delicate as the brain.

The research was recently published in the journal Science Translational Medicine.

Professor Housley discusses the new gene delivery technique in the UNSW video below.

More:

Cochlear implant enhances patient experience through gene therapy